Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

UNCY - Unicycive Therapeutics, Inc.... | Finranks

Home

/

UNCY

U

Unicycive Therapeutics, Inc. (UNCY)

NCM – Real Time Price. Currency in USD

5.39

+0.39 (7.80%)

Market open: Aug 12, 2026, 2:08 PM EDT

5.11

+0.11 (2.14%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

0

0

675K

951K

Cost of goods sold

-572K

-428K

-284K

-7K

Gross Profit

-572K

-428K

391K

944K

Operating expenses (excl. COGS)

-29M

-32M

-21M

-19M

Operating Income

-30M

-32M

-21M

-18M

Non-operating income, total

3M

-5M

-10M

-6K

Pretax income

-27M

-37M

-31M

-18M

Equity in earnings

0

0

0

0

Taxes

0

0

0

0

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-27M

-37M

-31M

-18M

Discontinued operations

0

0

0

0

Net income

-27M

-37M

-31M

-18M

Dilution adjustment

0

0

0

0

Preferred dividends

0

1M

867K

0

Name

2025

2024

2023

2022

Total assets

49M+55.2%

32M+123.2%

14M+403.6%

3M

Total current assets

49M

31M

13M

3M

Total non-current assets

174K

720K

792K

174K

Total liabilities

19M-21.9%

24M+34.6%

18M+448.1%

3M

Total current liabilities

19M

24M

18M

3M

Total non-current liabilities

0

117K

466K

0

Total equity

30M

7M

-4M

-466K

Total liabilities & shareholders' equities

49M

32M

14M

3M

Total debt

199K-74.3%

773K-4.7%

811K+423.2%

155K

Name

2025

2024

2023

2022

Cash from operating activities

-31M

-29M

-18M

-16M

Cash from investing activities

-12M

-72K

-12K

-2K

Cash from financing activities

46M

45M

28M

-471K

Free cash flow

-31M-9.4%

-29M-56.6%

-18M-16.9%

-16M